Clinical Trial Update: Mild, Moderate and Severe Renal Impairment Study [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics in gout patients across mild, moderate, and severe renal impairment; the trial is completed and results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Snippet

Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 1 | Status: COMPLETED | Results posted: 2017-04-25